FindTrial
Sign In

Redefining pathology workflows with a smarter grossing board

All in one grossing solution :Revolutionising pathology with the modified grossing board - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/11/097099
Enrollment
100
Registered
2025-11-07
Start date
Unknown
Completion date
Unknown
Last updated
2025-11-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C502- Malignant neoplasm of upper-innerquadrant of breast Health Condition 2: C504- Malignant neoplasm of upper-outerquadrant of breast

Interventions

Intervention1: Nil: Nil Intervention2: Nil: Nil Intervention3: Nil: Nil

Sponsors

MythiliB
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.large specimens requiring multiple labelled cassette spaces 2.specimens requiring inking and margin labelling 3.formalin fixed specimens

Exclusion criteria

Exclusion criteria: 1.small biopsy specimens 2.unlabelled specimens lacking proper identification 3.very large grossing bits not fitting cassette spaces of the grossing board

Design outcomes

Primary

MeasureTime frame
Improved grossing efficiency ,turn over time and accuracy using modified smart grossing board compared to conventional grossing setupTimepoint: 10mins—

Secondary

MeasureTime frame
lesser turn around time and effiecient work flow with lesser assistanceTimepoint: 10mins—

Countries

India

Contacts

Public ContactMythiliB

saveetha medical college and hospitals

Kartika25@gmail.com9003053146

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026